Susquehanna International Group
IDYA icon

Susquehanna International Group’s IDEAYA Biosciences IDYA Stock Holding History

Susquehanna International Group’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12M Sell
30,148
-16,561
-35% -$507K ﹤0.01% 7898
2026
Q1 		$1.56M Sell
46,709
-16,849
-27% -$565K ﹤0.01% 6777
2025
Q4 		$2.2M Buy
63,558
+18,234
+40% +$581K ﹤0.01% 5455
2025
Q3 		$1.23M Sell
45,324
-98,621
-69% -$2.39M ﹤0.01% 6843
2025
Q2 		$3.03M Buy
143,945
+14,210
+11% +$273K ﹤0.01% 4936
2025
Q1 		$2.13M Buy
129,735
+79,108
+156% +$1.69M ﹤0.01% 5393
2024
Q4 		$1.3M Buy
50,627
+15,571
+44% +$441K ﹤0.01% 6320
2024
Q3 		$1.11M Buy
35,056
+5,501
+19% +$209K ﹤0.01% 6546
2024
Q2 		$1.04M Sell
29,555
-8,054
-21% -$319K ﹤0.01% 6498
2024
Q1 		$1.65M Buy
37,609
+6,907
+22% +$297K ﹤0.01% 5776
2023
Q4 		$1.09M Buy
30,702
+11,370
+59% +$339K ﹤0.01% 6777
2023
Q3 		$522K Sell
19,332
-17,763
-48% -$450K ﹤0.01% 8129
2023
Q2 		$872K Sell
37,095
-26,808
-42% -$551K ﹤0.01% 7016
2023
Q1 		$877K Buy
63,903
+51,289
+407% +$854K ﹤0.01% 7167
2022
Q4 		$229K Sell
12,614
-30,659
-71% -$516K ﹤0.01% 9779
2022
Q3 		$646K Buy
43,273
+9,330
+27% +$121K ﹤0.01% 7769
2022
Q2 		$468K Buy
33,943
+1,289
+4% +$14.3K ﹤0.01% 8431
2022
Q1 		$365K Sell
32,654
-8,849
-21% -$130K ﹤0.01% 9766
2021
Q4 		$981K Buy
41,503
+24,688
+147% +$573K ﹤0.01% 7350
2021
Q3 		$429K Buy
+16,815
New +$393K ﹤0.01% 9768
2021
Q2 		– Sell
-10,739
Closed -$252K – 12871
2021
Q1 		$252K Buy
10,739
+202
+2% +$3.9K ﹤0.01% 10966
2020
Q4 		$148K Sell
10,537
-6,421
-38% -$87K ﹤0.01% 10259
2020
Q3 		$213K Buy
+16,958
New +$210K ﹤0.01% 9356
2020
Q2 		– Sell
-19,240
Closed -$79K – 10471
2020
Q1 		$79K Buy
19,240
+6,502
+51% +$46K ﹤0.01% 9454
2019
Q4 		$96K Buy
+12,738
New +$90.9K ﹤0.01% 9159

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Susquehanna International Group's IDYA Position: Q2 2026 in Review

Susquehanna International Group reduced its IDEAYA Biosciences (IDYA) stake by 35% in Q2 2026, selling an estimated $507K and leaving 30,148 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #7898.

Susquehanna International Group first reported a position in IDYA in Q4 2019 and has held it in 25 quarters since. The position peaked at $3.03M in Q2 2025. 286 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Susquehanna International Group held 30,148 shares of IDEAYA Biosciences worth $1.12M as of Q2 2026.
  • Susquehanna International Group sold 16,561 IDEAYA Biosciences shares in Q2 2026, an estimated $507K.
  • IDEAYA Biosciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #7898 holding.
  • Susquehanna International Group first reported a position in IDEAYA Biosciences in Q4 2019 and has held it in 25 quarters since.
  • Susquehanna International Group's IDEAYA Biosciences position peaked at $3.03M in Q2 2025.
  • 286 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.